Forum Markets, Inc. (FRMM)
5.30
-0.37
(-6.53%)
USD |
NASDAQ |
Sep 01, 15:49
Forum Markets Cash from Investing (Quarterly) : -17.79M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -17.79M |
| March 31, 2026 | 71.82M |
| December 31, 2025 | 124.74M |
| September 30, 2025 | -252.37M |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 38.97M |
| September 30, 2019 | -0.3881M |
| June 30, 2019 | 16.65M |
| March 31, 2019 | 53.00M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Abeona Therapeutics, Inc. | 15.69M |
| Corcept Therapeutics, Inc. | -29.24M |
| ACADIA Pharmaceuticals, Inc. | -8.529M |
| Alnylam Pharmaceuticals, Inc. | -363.46M |
| Anika Therapeutics, Inc. | -1.28M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -12.44M |
| Cash from Financing (Quarterly) | -31.57M |
| Free Cash Flow | -318.80M |
| Free Cash Flow Per Share (Quarterly) | -0.729 |
| Free Cash Flow to Equity (Quarterly) | -11.29M |
| Free Cash Flow to Firm (Quarterly) | -12.20M |
| Free Cash Flow Yield | -344.5% |